LBT — Electrophoresis, Cholesterol Via Esterase-Oxidase, Hdl Class I

FDA Device Classification

FDA product code LBT covers "Electrophoresis, Cholesterol Via Esterase-Oxidase, Hdl", a Class I medical device regulated under 21 CFR 862.1475. Submissions are reviewed by the Clinical Chemistry panel. At least 8 recent 510(k) clearances have been granted under this product code.

Classification details

Product Code
LBT
Device Class
Class I
Regulation Number
862.1475
Submission Type
510(k) Exempt
Review Panel
CH
Medical Specialty
Clinical Chemistry
Implant
No

Recent 510(k) clearances

K-NumberApplicantDevice NameDate
K000568Roche DiagnosticsHDL CHOLESTEROL PLUSAug 4, 2000
K990250MoraxHYDRAGEL LDL/HDL CHOL DIRECT KIT-P.N. 4005, HYDRAGEL 7 LDL/HDL CHOL DIRECT…Jun 18, 1999
K972015MoraxHYDRAGEL 7,15,30, CHOL-HDL KITOct 27, 1997
K904035Helena LaboratoriesREP ULTRA HDL,VLDL/LDL CHOLESTEROL SYSTEMNov 9, 1990
K894366Helena LaboratoriesREP HDL-8 KIT, NO. 3188, REP HDL-16 KIT, NO. 3187Aug 31, 1989
K882368Helena LaboratoriesREP HDL ELECTROPHORESIS METHODAug 8, 1988
K873547Helena LaboratoriesTITAN GEL HDL CHOLESTEROL KITOct 2, 1987
K790791Gelman SciencesELECTROPHORESIS REAGENT SET, HDLJun 15, 1979

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.